Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Hepatitis A vaccine in the last-minute traveler.

Connor BA.

Am J Med. 2005 Oct;118 Suppl 10A:58S-62S. Review.

PMID:
16271543
2.

Does the concurrent administration of an inactivated hepatitis A vaccine influence the immune response to other travelers vaccines?

Bock HL, Kruppenbacher JP, Bienzle U, De Clercq NA, Hofmann F, Clemens RL.

J Travel Med. 2000 Mar-Apr;7(2):74-8.

3.

A review of the long-term protection after hepatitis A and B vaccination.

Van Damme P, Van Herck K.

Travel Med Infect Dis. 2007 Mar;5(2):79-84. Epub 2006 Jun 19. Review.

PMID:
17298912
4.
5.
6.

The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.

Keystone JS, Hershey JH.

Int J Infect Dis. 2008 Jan;12(1):3-11. Epub 2007 Jul 20. Review.

7.

Preventing hepatitis A infections in travelers to endemic areas.

Koff RS.

Am J Trop Med Hyg. 1995 Dec;53(6):586-90. Review.

PMID:
8561258
8.

Control of a community-wide outbreak of hepatitis A by mass vaccination with inactivated hepatitis A vaccine.

Zamir C, Rishpon S, Zamir D, Leventhal A, Rimon N, Ben-Porath E.

Eur J Clin Microbiol Infect Dis. 2001 Mar;20(3):185-7.

PMID:
11347668
9.

Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use.

André F, Van Damme P, Safary A, Banatvala J.

Expert Rev Vaccines. 2002 Jun;1(1):9-23. Review.

PMID:
12908508
10.

Duration of protection from clinical hepatitis A disease after vaccination with VAQTA.

Wiens BL, Bohidar NR, Pigeon JG, Egan J, Hurni W, Brown L, Kuter BJ, Nalin DR.

J Med Virol. 1996 Jul;49(3):235-41.

PMID:
8818971
11.

Long-term protective effect of post-exposure Havrix administration during viral hepatitis Type A outbreaks.

Kohl I, Nemecek V, Summerová M, Chlíbek R, Nad'ová K, Mináriková O.

Eur J Epidemiol. 2006;21(12):893-9. Epub 2006 Dec 8.

PMID:
17160428
12.

Accelerated vaccination schedules provide protection against hepatitis A and B in last-minute travelers.

Nothdurft HD, Zuckerman J, Stoffel M, Dieussaert I, Van Damme P.

J Travel Med. 2004 Jul-Aug;11(4):260-1. Review. No abstract available.

13.

One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?

Lopez AS, Guris D, Zimmerman L, Gladden L, Moore T, Haselow DT, Loparev VN, Schmid DS, Jumaan AO, Snow SL.

Pediatrics. 2006 Jun;117(6):e1070-7.

PMID:
16740809
14.

Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers".

Ranney M, Partridge R, Jay GD, Rozzoli DE, Pandey P.

J Travel Med. 2006 Nov-Dec;13(6):329-33.

15.

Effect of postexposure vaccination in a chimpanzee model of hepatitis A virus infection.

Robertson BH, D'Hondt EH, Spelbring J, Tian H, Krawczynski K, Margolis HS.

J Med Virol. 1994 Jul;43(3):249-51.

PMID:
7931186
16.

[Effectiveness of post-exposure prophylaxis using live attenuated hepatitis Alpha vaccine (H(2) strain) among schoolchildren].

Wang X, Ma J, Xu Z, Liu H, Zhang Y, Han C.

Zhonghua Yi Xue Za Zhi. 2002 Jul 25;82(14):955-7. Chinese.

PMID:
12181087
17.

Hepatitis A and B booster recommendations: implications for travelers.

Zuckerman JN, Connor BA, von Sonnenburg F.

Clin Infect Dis. 2005 Oct 1;41(7):1020-6. Epub 2005 Aug 29. Review.

PMID:
16142669
19.

Vaccination of travelers against hepatitis A and B.

Löscher T, Keystone JS, Steffen R.

J Travel Med. 1999 Jun;6(2):107-14. Review.

20.

Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?

Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.

Pediatrics. 2006 Sep;118(3):e570-8.

PMID:
16950948

Supplemental Content

Support Center